-
Turoctocog alfa in the treatment of individuals with hemophilia A: review of quality of life data collected in Phase III trials
Stephanie Seremetis, Roshni Kulkarni, Antoine Regnault & Elena Santagostino
Review: Clinical Trail Outcomes: Clinical Investigation
-
Turoctocog alfa in the treatment of individuals with hemophilia A: review of quality of life data collected in Phase III trials
Stephanie Seremetis, Roshni Kulkarni, Antoine Regnault & Elena Santagostino
Review: Clinical Trail Outcomes: Clinical Investigation
-
Turoctocog alfa in the treatment of individuals with hemophilia A: review of quality of life data collected in Phase III trials
Stephanie Seremetis, Roshni Kulkarni, Antoine Regnault & Elena Santagostino
Review: Clinical Trail Outcomes: Clinical Investigation
-
Turoctocog alfa in the treatment of individuals with hemophilia A: review of quality of life data collected in Phase III trials
Stephanie Seremetis, Roshni Kulkarni, Antoine Regnault & Elena Santagostino
Review: Clinical Trail Outcomes: Clinical Investigation
-
Turoctocog alfa in the treatment of individuals with hemophilia A: review of quality of life data collected in Phase III trials
Stephanie Seremetis, Roshni Kulkarni, Antoine Regnault & Elena Santagostino
Review: Clinical Trail Outcomes: Clinical Investigation
-
Turoctocog alfa in the treatment of individuals with hemophilia A: review of quality of life data collected in Phase III trials
Stephanie Seremetis, Roshni Kulkarni, Antoine Regnault & Elena Santagostino
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory initiatives: aligning financial incentives with the needs of our patients
Kevin D Hill, Jennifer S Li, Christoph P Hornik
Editorial: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory initiatives: aligning financial incentives with the needs of our patients
Kevin D Hill, Jennifer S Li, Christoph P Hornik
Editorial: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory initiatives: aligning financial incentives with the needs of our patients
Kevin D Hill, Jennifer S Li, Christoph P Hornik
Editorial: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory initiatives: aligning financial incentives with the needs of our patients
Kevin D Hill, Jennifer S Li, Christoph P Hornik
Editorial: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory initiatives: aligning financial incentives with the needs of our patients
Kevin D Hill, Jennifer S Li, Christoph P Hornik
Editorial: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory initiatives: aligning financial incentives with the needs of our patients
Kevin D Hill, Jennifer S Li, Christoph P Hornik
Editorial: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
New hope for bendamustine in the treatment of non-Hodgkin lymphoma
News and Views: Clinical Investigation
-
New hope for bendamustine in the treatment of non-Hodgkin lymphoma
News and Views: Clinical Investigation
-
New hope for bendamustine in the treatment of non-Hodgkin lymphoma
News and Views: Clinical Investigation
-
New hope for bendamustine in the treatment of non-Hodgkin lymphoma
News and Views: Clinical Investigation
-
New hope for bendamustine in the treatment of non-Hodgkin lymphoma
News and Views: Clinical Investigation
-
New hope for bendamustine in the treatment of non-Hodgkin lymphoma
News and Views: Clinical Investigation
-
Erratum
Erratum: Clinical Investigation
-
Erratum
Erratum: Clinical Investigation
-
Erratum
Erratum: Clinical Investigation
-
Erratum
Erratum: Clinical Investigation
-
Erratum
Erratum: Clinical Investigation
-
Erratum
Erratum: Clinical Investigation
-
International investigator-driven clinical trials: challenges and opportunities for US - Europe cooperation through the US cooperative group networks
Denis Lacombe, Anastassia Negrouk, John Bean
Clinical Trail Outcomes: Clinical Investigation
-
International investigator-driven clinical trials: challenges and opportunities for US - Europe cooperation through the US cooperative group networks
Denis Lacombe, Anastassia Negrouk, John Bean
Clinical Trail Outcomes: Clinical Investigation
-
International investigator-driven clinical trials: challenges and opportunities for US - Europe cooperation through the US cooperative group networks
Denis Lacombe, Anastassia Negrouk, John Bean
Clinical Trail Outcomes: Clinical Investigation
-
International investigator-driven clinical trials: challenges and opportunities for US - Europe cooperation through the US cooperative group networks
Denis Lacombe, Anastassia Negrouk, John Bean
Clinical Trail Outcomes: Clinical Investigation
-
International investigator-driven clinical trials: challenges and opportunities for US - Europe cooperation through the US cooperative group networks
Denis Lacombe, Anastassia Negrouk, John Bean
Clinical Trail Outcomes: Clinical Investigation
-
International investigator-driven clinical trials: challenges and opportunities for US - Europe cooperation through the US cooperative group networks
Denis Lacombe, Anastassia Negrouk, John Bean
Clinical Trail Outcomes: Clinical Investigation